102 related articles for article (PubMed ID: 31938136)
1. Tripartite motif-containing protein 37 is overexpressed in human glioma and its downregulation inhibits human glioma cell growth
Chang C; Zhu S; Xu Z; Liu Y
Int J Clin Exp Pathol; 2018; 11(2):502-511. PubMed ID: 31938136
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.
Tang SL; Gao YL; Wen-Zhong H
Biomed Pharmacother; 2018 Mar; 99():59-64. PubMed ID: 29324313
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Tripartite Motif-Containing Protein 37 (TRIM37) Inhibits the Proliferation and Tumorigenesis in Colorectal Cancer Cells.
Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
Oncol Res; 2017 Jan; 25(1):115-122. PubMed ID: 28081740
[TBL] [Abstract][Full Text] [Related]
4. TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
Nishibeppu K; Komatsu S; Kiuchi J; Kishimoto T; Takashima Y; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Tsuda H; Otsuji E
J Cancer; 2021; 12(2):316-325. PubMed ID: 33391428
[No Abstract] [Full Text] [Related]
5. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
[TBL] [Abstract][Full Text] [Related]
6. Silencing TRIM37 inhibits the proliferation and migration of non-small cell lung cancer cells.
Ding Y; Lu Y; Xie X; Sheng B; Wang Z
RSC Adv; 2018 Oct; 8(64):36852-36857. PubMed ID: 35558931
[TBL] [Abstract][Full Text] [Related]
7. TRIM37 promoted the growth and migration of the pancreatic cancer cells.
Jiang J; Tian S; Yu C; Chen M; Sun C
Tumour Biol; 2016 Feb; 37(2):2629-34. PubMed ID: 26395261
[TBL] [Abstract][Full Text] [Related]
8. TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma.
Tao Y; Xin M; Cheng H; Huang Z; Hu T; Zhang T; Wang J
Oncol Lett; 2017 Dec; 14(6):6365-6372. PubMed ID: 29163677
[TBL] [Abstract][Full Text] [Related]
9. TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer.
Hu CE; Gan J
Mol Med Rep; 2017 Mar; 15(3):1057-1062. PubMed ID: 28098873
[TBL] [Abstract][Full Text] [Related]
10. Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.
Yan S; Han X; Xue H; Zhang P; Guo X; Li T; Guo X; Yuan G; Deng L; Li G
J Cell Biochem; 2015 Aug; 116(8):1680-92. PubMed ID: 25735962
[TBL] [Abstract][Full Text] [Related]
11. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase.
Kallijärvi J; Lahtinen U; Hämäläinen R; Lipsanen-Nyman M; Palvimo JJ; Lehesjoki AE
Exp Cell Res; 2005 Aug; 308(1):146-55. PubMed ID: 15885686
[TBL] [Abstract][Full Text] [Related]
12. TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1.
Xu M; Jiang B; Man Z; Zhu H
Transl Oncol; 2023 Sep; 35():101732. PubMed ID: 37379772
[TBL] [Abstract][Full Text] [Related]
13. TRIM37 inhibits PDGF-BB-induced proliferation and migration of airway smooth muscle cells.
Dai Y; Li Y; Cheng R; Gao J; Li Y; Lou C
Biomed Pharmacother; 2018 May; 101():24-29. PubMed ID: 29477054
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling.
Jiang J; Yu C; Chen M; Tian S; Sun C
Biochem Biophys Res Commun; 2015 Sep; 464(4):1120-1127. PubMed ID: 26208456
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TRIM37 Promotes Apoptosis and Suppresses Tumor Growth in Gastric Cancer by Inactivation of the ERK1/2 Pathway.
Zhu H; Chen Y; Zhang J; Qian C; Qiu W; Shen H; Shen Z
Onco Targets Ther; 2020; 13():5479-5491. PubMed ID: 32606764
[TBL] [Abstract][Full Text] [Related]
17. TRIM37 targets AKT in the growth of lung cancer cells.
Dong S; Pang X; Sun H; Yuan C; Mu C; Zheng S
Onco Targets Ther; 2018; 11():7935-7945. PubMed ID: 30510432
[TBL] [Abstract][Full Text] [Related]
18. TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axis.
Wang W; Xia Z; Farré JC; Subramani S
Autophagy; 2018; 14(9):1574-1585. PubMed ID: 29940807
[TBL] [Abstract][Full Text] [Related]
19. Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells.
Sun L; Li G; Dai B; Tan W; Zhao H; Li X; Wang A
Mol Med Rep; 2015 Sep; 12(3):3423-3431. PubMed ID: 26043756
[TBL] [Abstract][Full Text] [Related]
20. TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion.
Zhang Q; Zheng J; Wu W; Lian H; Iranzad N; Wang E; Yang L; Wang X; Jiang X
Cell Death Dis; 2023 Mar; 14(3):178. PubMed ID: 36870986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
